Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Moderna, Inc. and Catalent, Inc. today announced the expansion of their strategic collaboration to dedicate a new high-speed vial filling line for the manufacture of the Moderna COVID-19 Vaccine and potentially other investigational programs in ...
read more
Patient-focused pharmaceutical company continues to partner with hospitals and ambulatory surgery centers to meet increased demand for essential compounded sterile medication during, and beyond, COVID-19; 503B outsourcing supports patient safety and ...
read more
Leading specialist development pharma, Amzell B.V, has signed a license and development agreement with Amring Pharmaceuticals Inc., a subsidiary of SEVER Life Sciences B.V., for the commercial rights to one of its leading clinical-stage candidates.
read more
Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, is pleased to announce a manufacturing agreement expansion with AstraZeneca to include drug product ...
read more
StemExpress is excited to announce that we will be opening our eighth facility with our newest location in Reno, Nevada.
read more
Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, today announced the appointment of Dr. Martin Kessler as Chief Executive Officer (CEO) of Rentschler Biopharma Inc., the ...
read more
Alembic is voluntarily recalling one lot of Telmisartan Tablets, USP, 20 mg, packaged in 30-count bottles, Lot No. 1905005661 to the consumer level.
read more
Charles River has completed the previously announced acquisition of Cognate BioServices for approximately $875 million.
read more
GRAM announced that the company was recently audited by the Dutch Health and Youth Care Inspectorate and issued EU GMP certificate.
read more
Viroclinics-DDL and ENPICOM announced the approval of their joint MIT Zuid subsidy (SME Innovation Stimulation Top Sectors South Holland) application.
read more
Ovid announced the closing of the Royalty, License and Termination agreement under which Takeda secured global rights from Ovid to develop and commercialize soticlestat.
read more
Moderna has announced the Company has shipped the 100-millionth dose of its COVID-19 vaccine to the U.S. Government.
read more
HUYABIO has entered into a clinical collaboration agreement with Bristol-Myers Squibb to evaluate the combination of HUYABIO's HBI-8000.
read more
RenovaCare announced its Chairman, Chief Executive Officer, and President, Alan Rubino, has decided to retire.
read more
Wednesday, March 31, 2021
Asymchem has announced a dedicated expansion of API manufacturing facilities to provide clients with peptide and oligonucleotide products.
read more